Target intelligence / Profile preview

Prokaryotic ribosome 30S subunit (30S subunit)

Target
30S subunit
Molecular classification
Ribosome, Ribosomal subunit, RNA-protein complex, Other
01

Overview

The prokaryotic ribosome 30S subunit is the smaller component of the bacterial 70S ribosome, responsible for binding messenger RNA (mRNA) and controlling the accuracy of translation by monitoring the base pairing between codons on the mRNA and the anticodons on transfer RNA (tRNA). It consists of a single 16S rRNA molecule (about 1,500 nucleotides) and 21 ribosomal proteins (S1–S21), forming a complex macromolecular structure with a molecular mass around 0.85 MDa. During translation initiation, it binds initiation factors, mRNA, and initiator tRNA to form the initiation complex before joining with the 50S subunit to create a functional 70S ribosome. The 30S subunit is the binding site for several classes of antibiotics—such as aminoglycosides and tetracyclines—which inhibit protein synthesis by various mechanisms. Its critical role and unique structure make it a primary target for antibiotics that aim to inhibit bacterial infection with minimal effect on eukaryotic translation.

Other names
Prokaryotic small ribosomal subunit30S ribosomal subunitSmall subunit of prokaryotic ribosome
02

Mechanism of action

Inhibition of translation by binding to the 30S subunit, disrupting mRNA decoding or tRNA selection (e.g., aminoglycosides like streptomycin and paromomycin induce misreading of the genetic code; tetracyclines block the attachment of aminoacyl-tRNA to the A site)

03

Biological functions

Translation (protein synthesis)Decoding of mRNAFidelity control in translationRibosome assembly
04

Disease associations

Infection (as a key target of antibiotics that treat bacterial infections)
05

Safety considerations

Off-target effects on mitochondrial ribosomes in eukaryotic cells (because mitochondria have ribosomes more similar to prokaryotic ribosomes than cytosolic eukaryotic ribosomes)Ototoxicity and nephrotoxicity (notably with aminoglycosides)Bacterial resistance mechanisms (e.g., point mutations in 16S rRNA, ribosomal protection proteins)
06

Interacting drugs

Streptomycin

5 more in the full profile.

07

Biomarkers

Bacterial 16S rRNA gene (for identifying bacterial species and monitoring bacterial burden; not typically used to select patients for 30S-directed therapy but is central to microbiological diagnostics)

Beyond the preview

Go deeper on Prokaryotic ribosome 30S subunit (30S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prokaryotic ribosome 30S subunit (30S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call